ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ (SharpPS) โ€” ื”ืจื›ื™ื‘ ืœืจื™ื›ื•ื– ื•ื–ื™ื›ืจื•ืŸ ืฉื›ื•ืœื ืžื“ื‘ืจื™ื ืขืœื™ื•

ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ืœืจื™ื›ื•ื– ื•ื–ื™ื›ืจื•ืŸ ื”ืคืš ืœืื—ื“ ื”ืจื›ื™ื‘ื™ื ื”ื ื—ืงืจื™ื ื‘ื™ื•ืชืจ ื‘ืชื—ื•ื ืชืžื™ื›ืช ื”ืงื•ื’ื ื™ืฆื™ื”. ืื‘ืœ ืžื” ื–ื” ื‘ื“ื™ื•ืง, ืื™ืš ื–ื” ืขื•ื‘ื“, ื•ืžื” ืื•ืžืจ ื”ืžื“ืข? ื”ืžืืžืจ ื”ื–ื” ืขื•ื ื” ืขืœ ื”ื›ืœ.

ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ (SharpPS) โ€” ื”ืจื›ื™ื‘ ืœืจื™ื›ื•ื– ื•ื–ื™ื›ืจื•ืŸ ืฉื›ื•ืœื ืžื“ื‘ืจื™ื ืขืœื™ื•

ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ืœืจื™ื›ื•ื– ื•ื–ื™ื›ืจื•ืŸ ื”ืคืš ืœืื—ื“ ื”ืจื›ื™ื‘ื™ื ื”ื ื—ืงืจื™ื ื‘ื™ื•ืชืจ ื‘ืชื—ื•ื ืชืžื™ื›ืช ื”ืงื•ื’ื ื™ืฆื™ื”. ืื‘ืœ ืžื” ื–ื” ื‘ื“ื™ื•ืง, ืื™ืš ื–ื” ืขื•ื‘ื“, ื•ืžื” ืื•ืžืจ ื”ืžื“ืข? ื”ืžืืžืจ ื”ื–ื” ืขื•ื ื” ืขืœ ื”ื›ืœ.

ืจื’ืข ืœืคื ื™ ื”ื›ืœ - ืžื” ื–ื” ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ?

ืื ืื™ ืคืขื ื”ืจื’ืฉืช ืฉื”ืžื•ื— ืฉืœืš "ืขื•ื‘ื“ ืœืื˜", ืฉืืชื” ืžื—ืคืฉ ืžื™ืœื™ื ื‘ืืžืฆืข ืžืฉืคื˜, ืื• ืฉื”ืจื™ื›ื•ื– ืคืฉื•ื˜ ืœื ืžื” ืฉื”ื™ื” - ื›ื ืจืื” ืฉืžืขืช ืขืœ ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ. ื‘ืฉื ื™ื ื”ืื—ืจื•ื ื•ืช ื”ืคืš ื”ืจื›ื™ื‘ ื”ื–ื” ืœื ื•ืฉื ื—ื ื‘ืงื”ื™ืœืช ื”ืžื“ืข, ืชื•ืกืคื™ ื”ืชื–ื•ื ื”, ื•ื”ื‘ื™ื•ื”ืืงื™ื ื’.

ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ (Phosphatidylserine, ื‘ืงื™ืฆื•ืจ PS) ื”ื•ื ืคื•ืกืคื•ืœื™ืคื™ื“ - ืกื•ื’ ืฉืœ ืฉื•ืžืŸ ืžื™ื•ื—ื“ ืฉื ืžืฆื ื‘ืžืžื‘ืจื ื•ืช ืฉืœ ื›ืœ ืชืื™ ื”ื’ื•ืฃ, ืื‘ืœ ื‘ืจื™ื›ื•ื– ื’ื‘ื•ื” ื‘ืžื™ื•ื—ื“ ื‘ืžื•ื— ื”ืื ื•ืฉื™. ืœืžืขืฉื”, ื›-15% ืžื›ืœืœ ื”ืคื•ืกืคื•ืœื™ืคื™ื“ื™ื ื‘ืžื•ื— ื”ื ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ. ื”ื•ื ื—ืœืง ื‘ืœืชื™ ื ืคืจื“ ืžื”ืžื‘ื ื” ืฉืœ ื ื•ื™ืจื•ื ื™ื - ืชืื™ ื”ืขืฆื‘ ืฉืื—ืจืื™ื ืขืœ ื›ืœ ื—ืฉื™ื‘ื”, ื–ื™ื›ืจื•ืŸ, ื•ืขื™ื‘ื•ื“ ืžื™ื“ืข.

ืžื” ืชืคืงื™ื“ื• ืฉืœ ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ื‘ืžื•ื—?

ื›ื“ื™ ืœื”ื‘ื™ืŸ ืœืžื” PS ื›ืœ ื›ืš ื—ืฉื•ื‘, ื ืฆื˜ืจืš ืœืฆืœื•ืœ ืงืฆืช ืœื‘ื™ื•ืœื•ื’ื™ื” - ื‘ืฉืคื” ืคืฉื•ื˜ื”, ืžื•ื‘ื˜ื—.

ื›ืœ ื ื•ื™ืจื•ืŸ ื‘ืžื•ื— ืฉืœื ื• ืžื•ืงืฃ ื‘ืžืžื‘ืจื ื” โ€” ืงืจื•ื ื“ืง ืฉืžืคืจื™ื“ ื‘ื™ืŸ "ืคื ื™ื" ืœ"ื—ื•ืฅ" ืฉืœ ื”ืชื. ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ื”ื•ื ื—ืœืง ืžืจื›ื–ื™ ื‘ืงืจื•ื ื”ื–ื”. ื”ื•ื ืžืกื™ื™ืข ืœ:

  • ืฉืžื™ืจื” ืขืœ ื–ืจื™ืžืช ืžื™ื“ืข ื‘ื™ืŸ ื ื•ื™ืจื•ื ื™ื ื“ืจืš ืฉื™ืคื•ืจ ืชืคืงื•ื“ ื”ืงื•ืœื˜ื ื™ื
  • ืชืžื™ื›ื” ื‘ื™ื™ืฆื•ืจ ื ื•ื™ืจื•ื˜ืจื ืกืžื™ื˜ื•ืจื™ื ื›ืžื• ื“ื•ืคืžื™ืŸ ื•ืืฆื˜ื™ืœื›ื•ืœื™ืŸ โ€” ื”ืžืฉื“ืจื™ื ื”ื›ื™ืžื™ื™ื ื”ืื—ืจืื™ื ืขืœ ืจื™ื›ื•ื– ื•ืœืžื™ื“ื”
  • ื•ื™ืกื•ืช ืงื•ืจื˜ื™ื–ื•ืœ โ€” ื”ื•ืจืžื•ืŸ ื”ืกื˜ืจืก ืฉื‘ืขื•ื“ืฃ ืฉืœื• ืคื•ื’ืข ื‘ื–ื™ื›ืจื•ืŸ ื•ื‘ืงื•ื’ื ื™ืฆื™ื”
  • ืชืžื™ื›ื” ื‘ื ื™ื•ึผืจื•ึผืคืœืกื˜ื™ื•ึผืช โ€” ื™ื›ื•ืœืช ื”ืžื•ื— ืœื”ืกืชื’ืœ ื•ืœื‘ื ื•ืช ืงืฉืจื™ื ื—ื“ืฉื™ื

ืžื” ืื•ืžืจ ื”ืžื—ืงืจ ื”ืžื“ืขื™?

ื”ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ื”ื•ื ืื—ื“ ืžื”ืจื›ื™ื‘ื™ื ื”ื‘ื•ื“ื“ื™ื ืฉืงื™ื‘ืœื• "Qualified Health Claim" ืžื”-FDA ื”ืืžืจื™ืงืื™ - ื›ืœื•ืžืจ ื”ื›ืจื” ืจืฉืžื™ืช ื‘ืงืฉืจ ื‘ื™ืŸ ื”ืจื›ื™ื‘ ืœืชืžื™ื›ื” ืงื•ื’ื ื™ื˜ื™ื‘ื™ืช. ื–ื” ืœื ืžืขื˜.

ืžื—ืงืจ ืฉืคื•ืจืกื ื‘-Journal of Clinical Biochemistry and Nutrition (2010) ื‘ื—ืŸ ืงื‘ื•ืฆื” ืฉืœ ืžื‘ื•ื’ืจื™ื ืขื ืชืœื•ื ื•ืช ืขืœ ื™ืจื™ื“ื” ืงื•ื’ื ื™ื˜ื™ื‘ื™ืช. ืงื‘ื•ืฆืช ื”ื ื™ืกื•ื™ ืฉื ื˜ืœื” PS ื”ืจืืชื” ืฉื™ืคื•ืจ ืžื•ื‘ื”ืง ื‘ื–ื™ื›ืจื•ืŸ ืžื™ืœื•ืœื™ ื•ื‘ืžื”ื™ืจื•ืช ืขื™ื‘ื•ื“ ืžื™ื“ืข ืœืขื•ืžืช ืงื‘ื•ืฆืช ื”ืคืœืฆื‘ื•.

ืžื—ืงืจ ืž-Nutritional Neuroscience (2015) ื‘ื“ืง ืืช ื”ืฉืคืขืช PS ืขืœ ื™ืœื“ื™ื ืขื ืงืฉื™ื™ ืงืฉื‘ ื•ืจื™ื›ื•ื–. ื”ืžืžืฆืื™ื ื”ืฆื‘ื™ืขื• ืขืœ ืชืžื™ื›ื” ื‘ืฉื™ืคื•ืจ ื”ืจื™ื›ื•ื–, ื”ื–ื™ื›ืจื•ืŸ ืœื˜ื•ื•ื— ืงืฆืจ, ื•ื”ืงืฉื‘ ื”ื ื“ืจืฉ ืœืžืฉื™ืžื•ืช ืืงื“ืžื™ื•ืช.

ืกืงื™ืจื” ืฉืคื•ืจืกืžื” ื‘-Advances in Nutrition (2016) ืกื™ื›ืžื” ืขืฉืจื•ืช ืžื—ืงืจื™ื ืขืœ ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ื•ืžืฆืื” ืชืžื™ื›ื” ืขืงื‘ื™ืช ื‘ืชืคืงื•ื“ื™ื ืงื•ื’ื ื™ื˜ื™ื‘ื™ื™ื ืฉื•ื ื™ื, ื›ื•ืœืœ ื–ื™ื›ืจื•ืŸ, ืงืฉื‘, ื•ืžื”ื™ืจื•ืช ืชื’ื•ื‘ื”.

SharpPS - ืžื” ืžื™ื™ื—ื“ ืืช ื”ืฆื•ืจื” ื”ื–ื•?

ืœื ื›ืœ ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ื ื•ืฆืจ ืฉื•ื•ื”. SharpPS ื”ื•ื ืฉื ืžืกื—ืจื™ ืœืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ื”ืžื•ืคืง ืžืกื•ื™ื”, ืฉืขื‘ืจ ืชื”ืœื™ืš ื™ื™ืฆื•ืจ ืกืคืฆื™ืคื™ ืฉืžื‘ื˜ื™ื— ื˜ื•ื”ืจ ื’ื‘ื•ื” ื•ื™ื›ื•ืœืช ืกืคื™ื’ื” ืžื™ื˜ื‘ื™ืช. ื–ื• ื”ืฆื•ืจื” ืฉื ื—ืงืจื” ื‘ื”ืจื—ื‘ื” ื‘ื ื™ืกื•ื™ื™ื ืงืœื™ื ื™ื™ื ื•ื”ืคื›ื” ืœืชืงืŸ ื”ื–ื”ื‘ ื‘ืชืขืฉื™ื™ื”.

ื‘ื ื™ื’ื•ื“ ืœืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ืฉืžื•ืคืง ืžืจืงืžืช ืžื•ื— ื‘ืงืจ (ืฉื”ื™ื” ื ืคื•ืฅ ื‘ืขื‘ืจ ืืš ื ื–ื ื— ืžืกื™ื‘ื•ืช ื‘ื˜ื™ื—ื•ืช), SharpPS ืขืœ ื‘ืกื™ืก ืกื•ื™ื” ื ื—ืฉื‘ ืœื‘ื˜ื•ื—, ื ืงื™, ื•ืกื‘ื™ื‘ืชื™ ื™ื•ืชืจ.

ืžื™ ื ื”ื ื” ืžืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ?

ื”ืžื—ืงืจื™ื ืžืฆื‘ื™ืขื™ื ืขืœ ื›ืš ืฉืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ืขืฉื•ื™ ืœืชืžื•ืš ื‘ืžืกืคืจ ืื•ื›ืœื•ืกื™ื•ืช:

ืกื˜ื•ื“ื ื˜ื™ื ื•ืื ืฉื™ ืžืงืฆื•ืข ืขื ืขื•ืžืก ืงื•ื’ื ื™ื˜ื™ื‘ื™

ืจื™ื›ื•ื– ืžืžื•ืฉืš, ืœื™ืžื•ื“ ืœื‘ื—ื™ื ื•ืช, ืคื’ื™ืฉื•ืช ืื™ื ื˜ื ืกื™ื‘ื™ื•ืช โ€” ื›ืœ ืืœื• ืžื“ืœื“ืœื™ื ืžืฉืื‘ื™ื ืงื•ื’ื ื™ื˜ื™ื‘ื™ื™ื. PS ื ื—ืงืจ ื‘ื”ืงืฉืจ ืฉืœ ืชืžื™ื›ื” ื‘ื‘ื™ืฆื•ืขื™ื ืงื•ื’ื ื™ื˜ื™ื‘ื™ื™ื ื‘ืชื ืื™ ืขื•ืžืก.

ืžื‘ื•ื’ืจื™ื ืžืขืœ ื’ื™ืœ 40

ืจืžื•ืช ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ื‘ืžื•ื— ื™ื•ืจื“ื•ืช ื‘ืื•ืคืŸ ื˜ื‘ืขื™ ืขื ื”ื’ื™ืœ. ืžื—ืงืจื™ื ื”ืจืื• ืฉืชื•ืกืฃ PS ืขืฉื•ื™ ืœืชืžื•ืš ื‘ืฉืžื™ืจื” ืขืœ ื—ื“ื•ืช ืžื ื˜ืœื™ืช.

ืื ืฉื™ื ืชื—ืช ืกื˜ืจืก ื›ืจื•ื ื™

ืกื˜ืจืก ื’ื•ืจื ืœื”ืคืจืฉืช ืงื•ืจื˜ื™ื–ื•ืœ, ืฉืคื•ื’ืข ื‘ื–ื™ื›ืจื•ืŸ ื•ื‘ืงื•ื’ื ื™ืฆื™ื”. PS ื ื—ืงืจ ื‘ื”ืงืฉืจ ืฉืœ ื•ื™ืกื•ืช ืชื’ื•ื‘ืช ื”ืกื˜ืจืก.

ื›ืžื” ืœืงื—ืช ื•ืžืชื™?

ืžืจื‘ื™ืช ื”ืžื—ืงืจื™ื ื”ืฉืชืžืฉื• ื‘ืžื™ื ื•ืŸ ืฉืœ 100โ€“300 ืž"ื’ ืœื™ื•ื, ื›ืืฉืจ 300 ืž"ื’ ื ื—ืงืจื• ื‘ื”ืจื—ื‘ื” ืœืชืžื™ื›ื” ืงื•ื’ื ื™ื˜ื™ื‘ื™ืช. ืžื•ืžืœืฅ ืœื—ืœืง ืืช ื”ืžื™ื ื•ืŸ ืœืื•ืจืš ื”ื™ื•ื ื•ืœืงื—ืช ืขื ืืจื•ื—ื” ื”ืžื›ื™ืœื” ืฉื•ืžืŸ (ืžื” ืฉืžืฉืคืจ ืกืคื™ื’ื” ืฉืœ ืคื•ืกืคื•ืœื™ืคื™ื“ื™ื).

ื”ืฉืคืขื•ืช PS ืื™ื ืŸ ืžื™ื™ื“ื™ื•ืช โ€” ืžืจื‘ื™ืช ื”ืžื—ืงืจื™ื ื‘ื—ื ื• ืชืงื•ืคื•ืช ืฉืœ 6โ€“12 ืฉื‘ื•ืขื•ืช. ื›ืœื•ืžืจ, ื–ื” ืœื "ืื ืจื’ื™ื” ืžื™ื™ื“ื™ืช" ืืœื ืชืžื™ื›ื” ืืจื•ื›ืช ื˜ื•ื•ื—.

ืฉืืœื•ืช ื ืคื•ืฆื•ืช ืขืœ ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ

ื”ืื ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ื‘ื˜ื•ื— ืœืฉื™ืžื•ืฉ ืืจื•ืš ื˜ื•ื•ื—?

ื”ืžื—ืงืจื™ื ื”ืงื™ื™ืžื™ื ืžืฆื‘ื™ืขื™ื ืขืœ ืคืจื•ืคื™ืœ ื‘ื˜ื™ื—ื•ืช ื˜ื•ื‘. PS ืžื•ืคืง ืžืกื•ื™ื” (SharpPS) ื ื—ืฉื‘ ืœื‘ื˜ื•ื— ืœืฉื™ืžื•ืฉ ืจื‘-ืฉื ืชื™ ื‘ื”ืชืื ืœื”ื ื—ื™ื•ืช ื”ื™ืฆืจืŸ. ื›ืžื• ืชืžื™ื“, ืžื•ืžืœืฅ ืœื”ืชื™ื™ืขืฅ ืขื ืจื•ืคื ืื ื™ืฉ ืžืฆื‘ื™ื ืจืคื•ืื™ื™ื ืงื™ื™ืžื™ื.

ื”ืื ื™ืฉ ื”ื‘ื“ืœ ื‘ื™ืŸ ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ืœื‘ื™ืŸ "ืชื•ืกืคื™ ื–ื™ื›ืจื•ืŸ" ืื—ืจื™ื?

PS ื”ื•ื ืื—ื“ ืžื”ืจื›ื™ื‘ื™ื ืขื ื”ื’ื™ื‘ื•ื™ ื”ืžื—ืงืจื™ ื”ื—ื–ืง ื‘ื™ื•ืชืจ ื‘ืงื˜ื’ื•ืจื™ื™ืช ื”ื ื•ื˜ืจื•ืคื™ืงืก. ื‘ื ื™ื’ื•ื“ ืœืจื›ื™ื‘ื™ื ืจื‘ื™ื ื‘ืฉื•ืง, ืœ-PS ื™ืฉ ืžื—ืงืจื™ื ืงืœื™ื ื™ื™ื ืื ื•ืฉื™ื™ื (ืœื ืจืง ืขืœ ืขื›ื‘ืจื™ื) ื•ืืคื™ืœื• ื”ื›ืจื” ืžื”-FDA.

ื›ืžื” ื–ืžืŸ ืœื•ืงื— ืœืจืื•ืช ืชื•ืฆืื•ืช?

ืžืจื‘ื™ืช ื”ืžื—ืงืจื™ื ืžื“ื•ื•ื—ื™ื ืขืœ ืฉื™ื ื•ื™ื™ื ืœืื—ืจ 6โ€“12 ืฉื‘ื•ืขื•ืช ืฉืœ ืฉื™ืžื•ืฉ ืขืงื‘ื™. ื—ืฉื•ื‘ ืœื”ื™ื•ืช ืกื‘ืœื ื™ื™ื ื•ืœื ืœืฆืคื•ืช ืœืฉื™ื ื•ื™ ืžื™ื™ื“ื™.

ืจื•ืฆื” ืœื ืกื•ืช ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ืื™ื›ื•ืชื™?

ืชื•ืกืฃ Think ืฉืœ Harmony ืžื›ื™ืœ SharpPS โ€” ืคื•ืกืคื˜ื™ื“ื™ืœืกืจื™ืŸ ื‘ืฆื•ืจืชื• ื”ื ื—ืงืจืช ื‘ื™ื•ืชืจ โ€” ืœืฆื“ ืจื›ื™ื‘ื™ื ื ื•ืกืคื™ื ืœืชืžื™ื›ื” ื‘ืจื™ื›ื•ื– ื•ื‘ื‘ื™ืฆื•ืขื™ื ืงื•ื’ื ื™ื˜ื™ื‘ื™ื™ื. ื›ืฉืจ, ืžืื•ืฉืจ ืžืฉืจื“ ื”ื‘ืจื™ืื•ืช, ื•ืžื™ื•ืฆืจ ื‘ืกื˜ื ื“ืจื˜ื™ื ื”ื’ื‘ื•ื”ื™ื ื‘ื™ื•ืชืจ.

ืœืจื›ื™ืฉืช Think โ†
ืœืขื•ื“ ืžื™ื“ืข ืขืœ Think
ร—
ืœืขื•ื“ ืžื™ื“ืข ืขืœ Think ืœืขื•ื“ ืžื™ื“ืข ืขืœ Think

ืชื•ืกืฃ ืชื–ื•ื ื” ื”ืžืฉืœื‘ ื‘ืชื•ื›ื• ืืช ื›ืœืœ ืจื›ื™ื‘ื™ ื‘ื“ื’ืœ ื”ื ื—ืงืจื• ื‘ื”ืชืื ืœืฉื™ืคื•ืจ ืคื•ืงื•ืก, ื—ื“ื•ืช ื•ื–ื™ื›ืจื•ืŸ

ืชื•ืกืฃ ืชื–ื•ื ื” ื”ืžืฉืœื‘ ื‘ืชื•ื›ื• ืืช ื›ืœืœ ืจื›ื™ื‘ื™ ื‘ื“ื’ืœ ื”ื ื—ืงืจื• ื‘ื”ืชืื ืœืฉื™ืคื•ืจ ืคื•ืงื•ืก, ื—ื“ื•ืช ื•ื–ื™ื›ืจื•ืŸ